--- title: "Apimeds Clears Merger Hurdle While Nucor Boosts Q2 Outlook: The Niche US Stocks Reshaping Their Sectors" type: "News" locale: "en" url: "https://longbridge.com/en/news/293841670.md" description: "Nucor's strong USD 9.5 billion Q1 sales and Apimeds' resolved merger dispute highlight a broader wave of structural shifts. These niche equities are aggressively navigating 2026 through strategic expansions and corporate reorganizations." datetime: "2026-07-26T09:18:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293841670.md) - [en](https://longbridge.com/en/news/293841670.md) - [zh-HK](https://longbridge.com/zh-HK/news/293841670.md) --- # Apimeds Clears Merger Hurdle While Nucor Boosts Q2 Outlook: The Niche US Stocks Reshaping Their Sectors I'm told that beneath the surface of the broader market, a diverse group of niche US equities is undergoing the most significant overhaul we've seen since early 2026. From resolving months-long boardroom disputes to delivering blowout earnings, these companies are aggressively repositioning themselves for the second half of the year. ### NUCOR CORP (NUE.US) Nucor is proving the resilience of its flexible electric arc furnace model. For Q1 2026, the steel giant reported net sales of **USD 9.5 billion** with diluted EPS of USD 3.23. Management is highly optimistic, projecting Q2 2026 earnings per share to hit USD 4.57, representing a massive 76% jump year-over-year. ### APIMEDS PHARMACEUTICALS US INC (APUS.US) According to people familiar with the matter, the intense corporate battle has finally concluded. In May 2026, Apimeds announced a comprehensive settlement with Inscobee, clearing the path for its previously disclosed **USD 100 million** PIPE financing. This breakthrough allows the company to push forward with its Apitox therapy and restores its normal trading status on the NYSE American. ### CROWN HOLDINGS INC (CCK.US) Crown Holdings posted standout Q2 2026 financial results. The packaging leader reported adjusted EPS of **USD 2.49** on revenue of USD 3.7 billion, topping consensus estimates. Riding on a 5% increase in global beverage can volumes, the company confidently raised its full-year EPS guidance to a range of USD 8.30 to USD 8.50. ### Trident Digital Tech Holdings Ltd. (TDTH.US) This is perhaps one of the most radical structural shifts in the sector. Trident Digital is terminating its ADS program by mid-July 2026, plotting a 240-to-1 share consolidation, and converting USD 8 million of founder debt into equity. The endgame? A direct Nasdaq listing fueled by a strategic pivot toward enterprise artificial intelligence. ### REPLIMUNE GROUP INC (REPL.US) While Replimune missed analyst estimates with a Q4 2026 net loss, its clinical pipeline is nearing a massive catalyst. The FDA accepted the resubmitted Biologics License Application for its RP1 combo therapy in advanced melanoma, setting a target action date in early August 2026. An upcoming advisory committee meeting later this month will be critical. ### Also - **SINGAPORE TELECOMMUNICATIONS (SGAPY.US)**: While the CEO took a 17% pay cut in FY 2026 following network outages, the telecom group successfully offloaded its stake in Gulf Development for **USD 1 billion**. - **CALIX INC (CALX.US)**: The broadband platform announced its Q2 results in July, though it continues to navigate a class-action lawsuit alleging misleading Q1 margin disclosures related to component pre-purchases. - **KOHLS CORPORATION (KSS.US)**: Following the appointment of Elliott Rodgers as COO in June 2026, the department store is betting heavily on its July back-to-school campaign. - **SMJ INTL HLDGS INC (SMJF.US)**: The Singapore-based flooring specialist is still consolidating its market presence following a USD 10 million initial public offering late last year. - **XFLH CAPITAL CORPORATION (XFLH.RT.US)**: The specialized capital rights vehicle continues to hold its position in the broader market ahead of its long-term expiration date. _This article does not constitute investment advice._ ### Related Stocks - [APUS.US](https://longbridge.com/en/quote/APUS.US.md) - [NUE.US](https://longbridge.com/en/quote/NUE.US.md) - [SMJF.US](https://longbridge.com/en/quote/SMJF.US.md) - [CALX.US](https://longbridge.com/en/quote/CALX.US.md) - [KSS.US](https://longbridge.com/en/quote/KSS.US.md) - [XFLH.RT.US](https://longbridge.com/en/quote/XFLH.RT.US.md) - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) - [TDTH.US](https://longbridge.com/en/quote/TDTH.US.md) - [SGAPY.US](https://longbridge.com/en/quote/SGAPY.US.md) - [CCK.US](https://longbridge.com/en/quote/CCK.US.md) ## Related News & Research - [Nucor Shares Flat Despite Q2 Earnings Beat: Details](https://longbridge.com/en/news/293975338.md) - [Nucor Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts](https://longbridge.com/en/news/293893566.md) - [Singtel confirms talks with multiple parties over potential Optus stake sale](https://longbridge.com/en/news/294278178.md) - [Nucor (NUE): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/294193068.md) - [Is Crown Holdings (CCK) Cheap After Strong Earnings, A Dividend, And Buybacks?](https://longbridge.com/en/news/293925095.md)